These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 26163145

  • 1. Drug-induced cerebral glucose metabolism resembling Alzheimer's Disease: a case study.
    Riepe MW, Walther B, Vonend C, Beer AJ.
    BMC Psychiatry; 2015 Jul 11; 15():157. PubMed ID: 26163145
    [Abstract] [Full Text] [Related]

  • 2. Bihemispheric cerebral FDG PET correlates of cognitive dysfunction as assessed by the CERAD in Alzheimer's disease.
    Schönknecht OD, Hunt A, Toro P, Guenther T, Henze M, Haberkorn U, Schröder J.
    Clin EEG Neurosci; 2011 Apr 11; 42(2):71-6. PubMed ID: 21675596
    [Abstract] [Full Text] [Related]

  • 3. Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using 18F-FDG-PET.
    Li XY, Men WW, Zhu H, Lei JF, Zuo FX, Wang ZJ, Zhu ZH, Bao XJ, Wang RZ.
    Int J Mol Sci; 2016 Oct 18; 17(10):. PubMed ID: 27763550
    [Abstract] [Full Text] [Related]

  • 4. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.
    Ossenkoppele R, Zwan MD, Tolboom N, van Assema DM, Adriaanse SF, Kloet RW, Boellaard R, Windhorst AD, Barkhof F, Lammertsma AA, Scheltens P, van der Flier WM, van Berckel BN.
    Brain; 2012 Jul 18; 135(Pt 7):2115-25. PubMed ID: 22556189
    [Abstract] [Full Text] [Related]

  • 5. Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.
    Oh H, Madison C, Baker S, Rabinovici G, Jagust W.
    Brain; 2016 Aug 18; 139(Pt 8):2275-89. PubMed ID: 27190008
    [Abstract] [Full Text] [Related]

  • 6. [Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan].
    Banzo I, Quirce R, Martínez-Rodríguez I, Jiménez-Bonilla J, Portilla-Quattrociocchi H, Medina-Quiroz P, Ortega F, Rodríguez E, Mateo I, Vázquez-Higuera JL, de Arcocha M, Carril JM.
    Rev Esp Med Nucl; 2011 Aug 18; 30(5):301-6. PubMed ID: 21640440
    [Abstract] [Full Text] [Related]

  • 7. PET of brain amyloid and tau in mild cognitive impairment.
    Small GW, Kepe V, Ercoli LM, Siddarth P, Bookheimer SY, Miller KJ, Lavretsky H, Burggren AC, Cole GM, Vinters HV, Thompson PM, Huang SC, Satyamurthy N, Phelps ME, Barrio JR.
    N Engl J Med; 2006 Dec 21; 355(25):2652-63. PubMed ID: 17182990
    [Abstract] [Full Text] [Related]

  • 8. Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease.
    Chételat G, Villemagne VL, Pike KE, Ellis KA, Bourgeat P, Jones G, O'Keefe GJ, Salvado O, Szoeke C, Martins RN, Ames D, Masters CL, Rowe CC, Australian Imaging Biomarkers and Lifestyle Study of ageing (AIBL) Research Group.
    Brain; 2011 Mar 21; 134(Pt 3):798-807. PubMed ID: 21310725
    [Abstract] [Full Text] [Related]

  • 9. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
    Engler H, Forsberg A, Almkvist O, Blomquist G, Larsson E, Savitcheva I, Wall A, Ringheim A, Långström B, Nordberg A.
    Brain; 2006 Nov 21; 129(Pt 11):2856-66. PubMed ID: 16854944
    [Abstract] [Full Text] [Related]

  • 10. The neural substrates of episodic memory impairment in Alzheimer's disease as revealed by FDG-PET: relationship to degree of deterioration.
    Desgranges B, Baron JC, Lalevée C, Giffard B, Viader F, de La Sayette V, Eustache F.
    Brain; 2002 May 21; 125(Pt 5):1116-24. PubMed ID: 11960900
    [Abstract] [Full Text] [Related]

  • 11. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.
    Mattsson N, Insel PS, Donohue M, Landau S, Jagust WJ, Shaw LM, Trojanowski JQ, Zetterberg H, Blennow K, Weiner MW, Alzheimer's Disease Neuroimaging Initiative*.
    Brain; 2015 Mar 21; 138(Pt 3):772-83. PubMed ID: 25541191
    [Abstract] [Full Text] [Related]

  • 12. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Pontecorvo MJ, Devous MD, Navitsky M, Lu M, Salloway S, Schaerf FW, Jennings D, Arora AK, McGeehan A, Lim NC, Xiong H, Joshi AD, Siderowf A, Mintun MA, 18F-AV-1451-A05 investigators.
    Brain; 2017 Mar 01; 140(3):748-763. PubMed ID: 28077397
    [Abstract] [Full Text] [Related]

  • 13. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH, Schuck S, Dubois B, Lépine JP, Gallarda T, Olié JP, Goni S, Troy S.
    Encephale; 2003 Mar 01; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Brain structural, functional, and cognitive correlates of recent versus remote autobiographical memories in amnestic Mild Cognitive Impairment.
    Tomadesso C, Perrotin A, Mutlu J, Mézenge F, Landeau B, Egret S, de la Sayette V, Jonin PY, Eustache F, Desgranges B, Chételat G.
    Neuroimage Clin; 2015 Mar 01; 8():473-82. PubMed ID: 26106572
    [Abstract] [Full Text] [Related]

  • 19. Neurobiological correlates of depressive symptoms in people with subjective and mild cognitive impairment.
    Auning E, Selnes P, Grambaite R, Šaltytė Benth J, Haram A, Løvli Stav A, Bjørnerud A, Hessen E, Hol PK, Muftuler løndalen A, Fladby T, Aarsland D.
    Acta Psychiatr Scand; 2015 Feb 01; 131(2):139-47. PubMed ID: 25346330
    [Abstract] [Full Text] [Related]

  • 20. Impaired cerebral glucose metabolism in prodromal Alzheimer's disease differs by regional intensity normalization.
    Küntzelmann A, Guenther T, Haberkorn U, Essig M, Giesel F, Henze R, Schroeter ML, Schröder J, Schönknecht P.
    Neurosci Lett; 2013 Feb 08; 534():12-7. PubMed ID: 23182881
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.